The company also aims to exceed $120M in annual recurring revenue for its iX Suite technology.
Concentrix (CNXC) outlined a fiscal 2026 adjusted free cash flow target of $630M to $650M during its Q2 2026 earnings call. The guidance reflects accelerated business growth and strong contract signings.
The company reported a 400% year-over-year increase in iX Suite deals, driving momentum toward its $120M annual recurring revenue goal. Management highlighted record contract signings as a key driver of performance.
No immediate market reaction was disclosed in the call.